5Lukaski HC,Bolonchuk WW.Estimation of body fluid volumes using tetrapolar bioelectrical impedance measurements[J].Aviat Space Environ Med,1988,59(12):1163-1169.
7Lopot F,Nejedly B,Novotna H,et al.Age-related extracellular to total body water volume ratio (ECV/TBW)-can it be used for 'dry weight' determination in dialysis patients? Application of multifrequency bioimpedance measurement[J].Int J Artif Organs,2002,25(8):762-769.
8Fisch BJ,Spiegel DM.Assessment of excess fluid distribution in chronic hemodialysis patients using bioimpedance spectroscopy[J].Kidney Int,1996,49(4):1105-1109.
9Chen YC,Chen HH,Yeh JC,et al.Adjusting dry weight by extracellular volume and body composition in hemodialysis patients[J].Nephron,2002,92(1):91-96.
10Katzarski KS,Charra B,Luik AJ et al.Fluid state and blood pressure control in patients treated with long and short haemodialysis[J].Nephrol Dial Transplant,1999,14(2):369-375.
2[1]Cheriex EC, Leunissen KML, Jansen JHA, et al.Echography of the inferior vena cava is a simple and reliable tool for estimation of 'dry weight' in haemodialysis patients. Nephrol Dial Transplant, 1989,4: 563-568
3[2]Haug C, Metzele A, Steffgen J, et al. Increased brain natriuretic peptide and atrial natriuretic peptide plasma concentrations in dialysis-dependent chronic renal failure and in patients with elevated left ventricular filling pressure. Clin Investig, 1994,72:430-434
4[3]Takahashi M, Nagake Y, Ichikawa H, et al. Plasma concentrations of natriuretic peptides in patients on hemodialysis. Research communications in molecular pathology and pharmacology,1996,92(1)
5[4]Fishbane S, Natke E, Maesaka J.Role of volume overload in dialysis-refractory hypertension. Am J Kidney Dis, 1996,28:257-261
6[5]Lauster F, Heim JM, Drummer C, et al. Plasma cGMP level as a marker of the hydration state in renal replacement therapy. Kidney Int Suppl,1993,41:S57-9
7[6]Franz M, Pohanka E, Tribl B, et al. Living on chronic hemodialysis between dryness and fluid overload. Kidney Int Suppl,1997,59:S39-42
8[7]Osajima A, Okazaki M, Kato H,et al. Clinical significance of natriuretic peptides and cyclic GMP in hemodialysis patients with coronary artery disease. Am J Nephrol, 2001,21(2):112-9
9[8]Tetsuka T, Ando Y, Ono S, et al. Change in inferior vena caval diameter detected by ultrasonography during and after hemodialysis. ASAIO J, 1995,41(1):105-10
10[9]Katzarski K.S, Randmaa, Bergstrom: Influence of hemodialysis on intravascular volume and vasoactive hormones. Clinical Nephrology ,1999,52: 304-311
